Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on: October 03,2025 0

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on:October 03,2025 0

Restricted blood flow speeds tumor growth by aging the immune system, study finds

Updated on: September 06,2025 0

Restricted blood flow speeds tumor growth by aging the immune system, study finds

Updated on:September 06,2025 0

Dementia-like protein buildup found in pancreas cells before cancer develops

Updated on: September 06,2025 0

Dementia-like protein buildup found in pancreas cells before cancer develops

Updated on:September 06,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on: October 05,2025 0

No OS benefit for concurrent and consolidative durvalumab vs. consolidation alone in unresectable stage 3 NSCLC: Trial

Updated on:October 05,2025 0

Immunotherapy helps extend the lives of patients with rare form of skin cancer

Updated on: September 06,2025 0

Immunotherapy helps extend the lives of patients with rare form of skin cancer

Updated on:September 06,2025 0

Promising new combo therapy found for drug-resistant melanoma

Updated on: September 06,2025 0

Promising new combo therapy found for drug-resistant melanoma

Updated on:September 06,2025 0

Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents

Updated on: October 04,2025 0

Proof-of-concept innate immune checkpoint inhibitor shows promise against solid tumors in rodents

Updated on:October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on: October 04,2025 0

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

Updated on:October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on: October 04,2025 0

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer

Updated on:October 04,2025 0

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

Updated on: October 05,2025 0

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

Updated on:October 05,2025 0